Cargando…
Treatment of Atopic Dermatitis Using a Full-Body Blue Light Device (AD-Blue): Protocol of a Randomized Controlled Trial
BACKGROUND: Irradiation with visible blue light (wavelength 400-495 nm) is a promising, effective, and safe new treatment option for chronic inflammatory skin diseases such as psoriasis and atopic dermatitis. OBJECTIVE: We will perform a multicenter, placebo-controlled, double-blinded, 3-armed, pros...
Autores principales: | Kromer, Christian, Nühnen, Viktoria P, Pfützner, Wolfgang, Pfeiffer, Sebastian, Laubach, Hans-Joachim, Boehncke, Wolf-Henning, Liebmann, Joerg, Born, Matthias, Schön, Michael P, Buhl, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329412/ https://www.ncbi.nlm.nih.gov/pubmed/30622089 http://dx.doi.org/10.2196/11911 |
Ejemplares similares
-
Clinical Efficacy of Blue Light Full Body Irradiation as Treatment Option for Severe Atopic Dermatitis
por: Becker, Detlef, et al.
Publicado: (2011) -
A Dynamic Model for Prediction of Psoriasis Management by Blue Light Irradiation
por: Félix Garza, Zandra C., et al.
Publicado: (2017) -
Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis
por: Buhl, Timo, et al.
Publicado: (2020) -
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
por: Simpson, Eric L., et al.
Publicado: (2022) -
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
por: Thyssen, Jacob P., et al.
Publicado: (2021)